Drug General Information |
Drug ID |
D0A2GB
|
Former ID |
DNC004617
|
Drug Name |
3-(4-Amino-phenyl)-3-pentyl-piperidine-2,6-dione
|
Drug Type |
Small molecular drug
|
Indication |
Discovery agent
|
Investigative |
[1]
|
Structure |
|
Download
2D MOL
3D MOL
|
Formula |
C16H22N2O2
|
Canonical SMILES |
CCCCCC1(CCC(=O)NC1=O)C2=CC=C(C=C2)N
|
InChI |
1S/C16H22N2O2/c1-2-3-4-10-16(11-9-14(19)18-15(16)20)12-5-7-13(17)8-6-12/h5-8H,2-4,9-11,17H2,1H3,(H,18,19,20)
|
InChIKey |
VFLOMQQDKBQIOE-UHFFFAOYSA-N
|
PubChem Compound ID |
|
Target and Pathway |
Target(s) |
Cytochrome P450 19 |
Target Info |
Inhibitor |
[1]
|
Cytochrome P450 11A1, mitochondrial |
Target Info |
Inhibitor |
[1]
|
BioCyc Pathway
|
Superpathway of steroid hormone biosynthesis
|
Estradiol biosynthesis II
|
Estradiol biosynthesis IPWY-7305:Superpathway of steroid hormone biosynthesis
|
Pregnenolone biosynthesis
|
KEGG Pathway
|
Steroid hormone biosynthesis
|
Metabolic pathways
|
Ovarian steroidogenesishsa00140:Steroid hormone biosynthesis
|
Ovarian steroidogenesis
|
NetPath Pathway
|
FSH Signaling PathwayNetPath_25:FSH Signaling Pathway
|
PANTHER Pathway
|
Androgen/estrogene/progesterone biosynthesis
|
PathWhiz Pathway
|
Androgen and Estrogen MetabolismPW000141:Steroidogenesis
|
Reactome
|
Endogenous sterolsR-HSA-211976:Endogenous sterols
|
WikiPathways
|
Metapathway biotransformation
|
Tryptophan metabolism
|
Oxidation by Cytochrome P450
|
Ovarian Infertility Genes
|
Metabolism of steroid hormones and vitamin D
|
FSH signaling pathway
|
Integrated Breast Cancer Pathway
|
Phase 1 - Functionalization of compoundsWP98:Prostaglandin Synthesis and Regulation
|
Glucocorticoid & Mineralcorticoid Metabolism
|
Corticotropin-releasing hormone
|
Phase 1 - Functionalization of compounds
|
References |
REF 1 | J Med Chem. 1986 Aug;29(8):1362-9.Aromatase inhibitors. Synthesis and evaluation of mammary tumor inhibiting activity of 3-alkylated 3-(4-aminophenyl)piperidine-2,6-diones. |